Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.35% |
| 2 | Technology | 8.73% |
| 3 | Financials | 7.42% |
| 4 | Healthcare | 6.65% |
| 5 | Industrials | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
Amerant Bancorp
AMTB
$1.13B
| $932K | ﹤0.01% |
51,137
-10,291
| -17% | -$183K |
|
4352
PUT
Ambarella
AMBA
$3.12B
| $932K | ﹤0.01% |
14,100
-4,900
| -26% | -$260K |
|
4353
Actinium Pharmaceuticals
ATNM
$31.4M
| $929K | ﹤0.01% |
+663,269
| New | +$993K |
|
4354
Ichor Holdings
ICHR
$2.21B
| $927K | ﹤0.01% |
47,219
+26,346
| +126% | +$483K |
|
4355
Harmony Biosciences
HRMY
$2.32B
| $926K | ﹤0.01% |
29,289
-49,203
| -63% | -$1.58M |
|
4356
PUT
Sysco
SYY
$39.5B
| $924K | ﹤0.01% |
12,200
-19,300
| -61% | -$1.4M |
|
4357
Regenxbio
RGNX
$619M
| $919K | ﹤0.01% |
111,949
-220,880
| -66% | -$1.85M |
|
4358
Opko Health
OPK
$1.12B
| $918K | ﹤0.01% |
695,780
-5,691,131
| -89% | -$7.78M |
|
4359
CALL
Asana
ASAN
$2.34B
| $918K | ﹤0.01% |
68,000
-163,700
| -71% | -$2.57M |
|
4360
OmniAb
OABI
$670M
| $917K | ﹤0.01% |
650,316
+518,645
| +394% | +$868K |
|
4361
FS Bancorp
FSBW
$336M
| $916K | ﹤0.01% |
23,251
+1,898
| +9% | +$73.5K |
|
4362
PUT
NetEase
NTES
$78.6B
| $915K | ﹤0.01% |
6,800
-4,700
| -41% | -$540K |
|
4363
Gevo
GEVO
$415M
| $915K | ﹤0.01% |
693,251
-2,585,010
| -79% | -$3.03M |
|
4364
Stratasys
SSYS
$699M
| $914K | ﹤0.01% |
79,690
+20,604
| +35% | +$209K |
|
4365
TScan Therapeutics
TCRX
$50.8M
| $914K | ﹤0.01% |
630,138
+398,963
| +173% | +$576K |
|
|
NPB
4366
Northpointe Bancshares
NPB
$592M
| $911K | ﹤0.01% |
66,482
-105,795
| -61% | -$1.42M |
|
4367
Burke & Herbert Financial Services Corp
BHRB
$1.45B
| $909K | ﹤0.01% |
15,225
-14,372
| -49% | -$796K |
|
|
AKRO
4368
CALL
DELISTED
Akero Therapeutics
AKRO
| $907K | ﹤0.01% |
17,000
+2,000
| +13% | +$90.9K |
|
4369
PUT
Peabody Energy
BTU
$3.59B
| $905K | ﹤0.01% |
67,400
-117,300
| -64% | -$1.55M |
|
4370
Monarch Casino & Resort
MCRI
$2.22B
| $904K | ﹤0.01% |
10,463
-9,050
| -46% | -$730K |
|
4371
NRC Health Common Stock
NRC
$487M
| $904K | ﹤0.01% |
53,810
+11,770
| +28% | +$159K |
|
4372
Neumora Therapeutics
NMRA
$278M
| $903K | ﹤0.01% |
1,231,392
+513,066
| +71% | +$389K |
|
4373
PUT
Air Products & Chemicals
APD
$68B
| $903K | ﹤0.01% |
3,200
-1,400
| -30% | -$383K |
|
4374
CALL
McCormick & Company Non-Voting
MKC
$14.7B
| $902K | ﹤0.01% |
11,900
+600
| +5% | +$45K |
|
4375
CALL
OneMain Financial
OMF
$7.35B
| $901K | ﹤0.01% |
15,800
-3,500
| -18% | -$175K |
|
Similar funds
Israel Englander's Q2 2025 Portfolio in Review
As of Q2 2025, Israel Englander held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Israel Englander added most to Applovin in Q2 2025, an estimated $751M increase.
- Israel Englander's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Israel Englander fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Israel Englander's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Israel Englander opened 738 new positions and closed 712 in Q2 2025.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.